Company Filing History:
Years Active: 1999-2006
Title: Wongi Seol: Innovator in Retinoid X Receptor Research
Introduction
Wongi Seol is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biochemistry, particularly in the study of retinoid X receptors. With a total of 2 patents, his work has implications for understanding protein interactions and their biological significance.
Latest Patents
Wongi Seol's latest patents include innovative methods for determining the interaction between test proteins and retinoid X receptor proteins. One of his patents discloses a method that involves providing a host cell containing a reporter gene linked to a protein binding site. This method utilizes fusion genes to express proteins that can indicate whether a test protein interacts with the retinoid X receptor. Additionally, he has developed purified DNA encoding retinoid X receptor-interacting proteins, which further enhances the understanding of these critical biological interactions.
Career Highlights
Wongi Seol is currently associated with The General Hospital Corporation, where he continues to advance his research. His work has been instrumental in exploring the mechanisms of protein interactions, which are vital for various biological processes.
Collaborations
Throughout his career, Wongi has collaborated with notable colleagues, including David D Moore and Hueng-Sik Choi. These collaborations have enriched his research and contributed to the advancement of knowledge in his field.
Conclusion
Wongi Seol's innovative research and patents in the area of retinoid X receptors highlight his role as a key inventor in biochemistry. His contributions are paving the way for future discoveries in protein interactions and their implications in health and disease.